Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorViome
About this trial
The purpose of the study is to collect and analyze physiological, physical, and molecular data from a diverse population to increase our understanding of how such parameters are associated with health and disease.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Anyone that resides in the US at the time of enrollment.
Disqualifiers
None
Trial population
Participants with specific phenotypes of interest and matched healthy controls.
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
No Intervention
Other interventionThis is an observational study, there are no interventions.
Treatment groups
20,000 Participants
are divided into 2 treatment groupsGroup A: Healthy Control1 intervention
Group B: Cases (Various Phenotypes)1 intervention
Trial outcomes
Primary outcomes
1
Molecular Determinants of Health and Disease
We measure thousands of transcript levels in multiple clinical samples. The primary outcome measures are changes in quantitative gene expression, microbial or human, as a result of transitioning from a healthy state to a disease.
Time frame
10 years Source ClinicalTrials.gov